((R)-4,4-DIMETHYLPYRROLIDIN-2-YL)METHANOL, 95.0%, 1g

8-Bromo-3-methyl-2,3,4,9-tetrahydro-1h-carbazole, 98%, 5g

3,6-Dichlorobenzo[d]isoxazole, 95.0%, 5g

1-(4-Hydroxypiperidin-1-yl)ethanone, 95.0%, 5g

N-Boc-2,6-Dimethyl-D-tyrosine, 1g

4-(Chloromethyl)thiazole hydrochloride, 97.0%, 100g

1-pentanolo, minimo 98%, per sintesi, 1 L, confezione in vetro

N-[(2S)-6,8-Difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]-L-norvaline, 97%, 1g

Bis(2,5-dioxopyrrolidin-1-yl) 4,7,10,13,16-pentaoxanonadecane-1,19-dioate, 98+%, 250mg

2-methyl-3-[(2-pyridinylmethyl)amino]benzoic acid, 95.0%, 5g

8-Chloroisoquinolin-5-amine, 95.0%, 250mg

(4-((3-(Trifluoromethyl)phenoxy)methyl)phenyl)boronic acid, 95.0%, 5g

3-Formylbenzoic acid, 95.0%, 25g